featured
Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials
J. Clin. Oncol 2022 Feb 04;[EPub Ahead of Print], JM Unger, R Vaidya, KS Albain, M LeBlanc, LM Minasian, CC Gotay, NL Henry, MJ Fisch, SM Lee, CD Blanke, DL HershmanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.